JP2020516684A5 - - Google Patents

Download PDF

Info

Publication number
JP2020516684A5
JP2020516684A5 JP2020505949A JP2020505949A JP2020516684A5 JP 2020516684 A5 JP2020516684 A5 JP 2020516684A5 JP 2020505949 A JP2020505949 A JP 2020505949A JP 2020505949 A JP2020505949 A JP 2020505949A JP 2020516684 A5 JP2020516684 A5 JP 2020516684A5
Authority
JP
Japan
Prior art keywords
lactobacillus
zeae
buchneri
cell
medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020505949A
Other languages
English (en)
Japanese (ja)
Other versions
JP7494110B2 (ja
JP2020516684A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2018/050326 external-priority patent/WO2018187838A1/en
Publication of JP2020516684A publication Critical patent/JP2020516684A/ja
Publication of JP2020516684A5 publication Critical patent/JP2020516684A5/ja
Application granted granted Critical
Publication of JP7494110B2 publication Critical patent/JP7494110B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020505949A 2017-04-11 2018-04-11 炎症及び炎症性疾患の治療法 Active JP7494110B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AU2017901320 2017-04-11
AU2017901320A AU2017901320A0 (en) 2017-04-11 Methods for the treatment of inflammation and inflammatory conditions
AU2017902271A AU2017902271A0 (en) 2017-06-15 Methods for the treatment of inflammation and inflammatory conditions
AU2017902271 2017-06-15
PCT/AU2018/050326 WO2018187838A1 (en) 2017-04-11 2018-04-11 Methods for the treatment of inflammation and inflammatory conditions

Publications (3)

Publication Number Publication Date
JP2020516684A JP2020516684A (ja) 2020-06-11
JP2020516684A5 true JP2020516684A5 (enExample) 2021-07-26
JP7494110B2 JP7494110B2 (ja) 2024-06-03

Family

ID=63792160

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020505949A Active JP7494110B2 (ja) 2017-04-11 2018-04-11 炎症及び炎症性疾患の治療法

Country Status (8)

Country Link
US (2) US20200376047A1 (enExample)
EP (1) EP3609515A4 (enExample)
JP (1) JP7494110B2 (enExample)
CN (1) CN110753553A (enExample)
AU (1) AU2018251616B2 (enExample)
CA (1) CA3059453A1 (enExample)
SG (1) SG11201908857QA (enExample)
WO (1) WO2018187838A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109172613B (zh) 2018-08-14 2022-04-22 景岳生物科技(中国)有限公司 含乳杆菌死菌培养物的皮肤外用组合物及其于促进伤口愈合及降低疤痕产生的用途
AU2019356524A1 (en) * 2018-10-10 2021-05-13 Servatus Ltd Methods of treatment of inflammatory conditions and associated infections
GB201905386D0 (en) * 2019-04-16 2019-05-29 Probi Ab Probiotic compositions and uses thereof
EP3815700A1 (en) * 2019-10-30 2021-05-05 Biomillenia SAS Medical compositions and their use in treating inflammatory bowel disease
US12329181B2 (en) * 2020-02-28 2025-06-17 Terragen Holdings Limited Microbial feed supplement composition and method
CN115551524A (zh) * 2020-03-31 2022-12-30 赛瓦图斯有限公司 用于炎性肠病的组合疗法
CN111733110B (zh) * 2020-07-17 2021-10-22 佛山市朗芯生物科技有限公司 副干酪乳杆菌及其在制备治疗溃疡性结肠炎药物中的应用
CN114470007B (zh) * 2020-11-13 2024-10-18 葡萄王生技股份有限公司 含乳酸菌发酵产物之皮肤创伤外用组合物及其用途
WO2022115907A1 (en) * 2020-12-01 2022-06-09 Servatus Ltd Methods for improving sleep quality
AU2021397808A1 (en) * 2020-12-09 2023-07-06 Servatus Ltd Combination therapy for inflammatory disorders of the joints
CN112522160B (zh) * 2020-12-24 2022-05-10 广东省科学院微生物研究所(广东省微生物分析检测中心) 一株具有抗病毒能力的发酵乳杆菌pv22及其应用
KR102268128B1 (ko) * 2021-02-09 2021-06-22 주식회사 락토메이슨 모유 유래 신규한 락토바실러스 루테리 lm1071 균주, 및 상기 균주 또는 이의 배양물을 포함하는 월경전 증후군 완화용 조성물
CN114456967B (zh) * 2021-10-14 2022-10-04 命之源(杭州)生物科技有限公司 一种酵母、乳酸菌联合菌、培育方法及其应用
WO2023097375A1 (en) * 2021-12-02 2023-06-08 Servatus Ltd Methods for the treatment of constipation
KR102879081B1 (ko) * 2023-03-28 2025-11-05 제이에스바이오컴퍼니 주식회사 락토바실러스 파카라제이 및 락토바실러스 부크네리를 포함하는 유산균 배양액 제조 방법 및 이를 이용한 피부 개선 기능성 원료 제조 방법
IL327017A (en) * 2023-09-08 2026-05-01 Marvelbiome Inc Methods for treating diseases and conditions related to lipid and cholesterol metabolism

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE490776T1 (de) * 2000-10-06 2010-12-15 Nestec Sa Verwendung von probiotischen milchsäure- produzierende bakterien zur zum schutz der haut gegen uv-induzierter allergischen reaktionen und entzündungskrankheiten oder immunsuppression
US20030175305A1 (en) 2002-01-08 2003-09-18 Garner Bryan E. Compositions and methods for inhibiting pathogenic growth
US20040208863A1 (en) * 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria
AU2013201442B2 (en) * 2005-09-28 2014-10-30 Nordic Rebalance A/S Treatment of IBD and IBS using both probiotic bacteria and fermented cereal as treatment effectors
WO2008064893A1 (en) * 2006-12-01 2008-06-05 Organobalance Gmbh Compositions, kits and uses for protecting the skin against pathogenic microorganisms
KR100858840B1 (ko) 2007-03-05 2008-09-17 (주)네오팜 신규 유산균 균주 및 이를 포함하는 유산균 제제
WO2009043171A1 (en) * 2007-10-02 2009-04-09 Institut National De La Recherche Scientifique Method of regulating the th17 pathway and its associated metabolic impact
WO2012039615A2 (en) * 2010-09-21 2012-03-29 Winclove Bio Industries B.V. Commensal rat ileum bacterium (crib)
CN103648511B (zh) * 2011-06-08 2018-12-07 诺沃奇梅兹有限公司 喷雾干燥的乳杆菌属菌株/细胞及其对抗幽门螺杆菌的用途
RU2628411C2 (ru) 2011-11-04 2017-08-16 Терраджен Холдингз Лимитед Микробные инокулянты и содержащие их композиции удобрений
MX2015006491A (es) * 2012-11-23 2015-12-03 Seres Health Inc Composiciones bacterianas sinergicas y metodos de produccion y uso de las mismas.
US20160066582A1 (en) * 2013-04-23 2016-03-10 Terragen Holdings Limited Bacterial strains having antimicrobial activity and biocontrol compositions comprising the same
AR101538A1 (es) 2014-09-25 2016-12-28 Terragen Holdings Ltd Cepas bacterianas que tienen actividad antimicrobiana y composiciones de biocontrol que las comprenden

Similar Documents

Publication Publication Date Title
Schnupf et al. Modulation of the gut microbiota to improve innate resistance
Lin et al. Impact of the gut microbiota, prebiotics, and probiotics on human health and disease
JP2024129016A5 (enExample)
JP2024003162A (ja) クロストリジウム・ディフィシル感染症の治療における新たな使用
RU2011139211A (ru) Бактериальные штаммы, обладающие высокой противовоспалительной активностью
CN112553115B (zh) 植物乳杆菌zdy2013在制备缓解肾损伤产品中应用
Praet et al. Bifidobacterium commune sp. nov. isolated from the bumble bee gut
BR112018071271A2 (pt) bactérias do ácido láctico para produto alimentício tratado com calor para armazenamento em temperatura ambiente
JP7228200B2 (ja) 新規のプロバイオティックなラクトバチルス・カゼイ株及びその使用
Vanmaele et al. Characterization of the virulence of Harveyi clade vibrios isolated from a shrimp hatchery in vitro and in vivo, in a brine shrimp (Artemia franciscana) model system
CN113564068A (zh) 植物乳杆菌1201及其在制备抑制鼠伤寒沙门氏菌产品中的应用
CN114672436B (zh) 一株嗜酸乳杆菌及其应用
Cao et al. First report of Pectobacterium parmentieri causing blackleg on potato in Inner Mongolia, China
Handique et al. First report of Pectobacterium punjabense causing blackleg and soft rot on potato in Hebei and Fujian province, China
CN109385387A (zh) 一种抗tgev的罗伊氏乳杆菌及其应用
Istiqomah et al. Cholesterol assimilation of Saccharomyces cerevisiae B-18 isolated from gastrointestinal tract of Javanese duck.
Handique et al. First report of Pectobacterium polaris causing blackleg on potato in inner Mongolia and sichuan province, China
Calo-Mata et al. Intestinal microbiota: first barrier against gut-affecting pathogens
CN118879583B (zh) 一株具有免疫调节和降尿酸功能的植物乳植杆菌cn211及其应用
JPH0930981A (ja) 免疫賦活組成物
CN110591986B (zh) 一株可缓解类风湿性关节炎的干酪乳杆菌及其应用
JP6152231B1 (ja) 腸内フローラ改善剤
Hua et al. First report of wilt disease of ginger caused by Achromobacter xylosoxidans in China
KR20210067274A (ko) 붉바리 양식용 미생물 제제
CN115873765A (zh) 一株类肠膜魏斯氏菌MbWp-1及其产品与应用